LAZARI CAPITAL MANAGEMENT, INC.
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1986389
WOODLAND HILLS, CA
Position in LCTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$13,755
-$2,835 QoQ
Shares Held
10,500
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 130 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARI CAPITAL MANAGEMENT, INC. holds $860,649 across 6 Biotechnology names. LCTX ranks #4 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MESO |
Mesoblast Ltd
|
47,421 | $641,606 | |
| 2 | GERN |
Geron Corp
|
117,424 | $150,302 | |
| 3 | MAIA |
MAIA Biotechnology, Inc.
|
21,750 | $31,320 | |
| 4 | LCTX |
Lineage Cell Therapeutics, Inc.
This page
|
10,500 | $13,755 | |
| 5 | VANI |
Vivani Medical, Inc.
|
10,000 | $12,400 | |
| 6 | HUMA |
Humacyte, Inc.
|
14,444 | $11,266 |
All Filings in LCTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,755 | 10,500 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $16,590 | 10,500 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $17,535 | 10,500 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $18,280 | 10,817 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $9,843 | 10,817 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,867 | 10,817 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $5,482 | 10,964 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||